Michael Morneau
Verwaltungsdirektor bei VIKING THERAPEUTICS, INC.
Aktive Positionen von Michael Morneau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIKING THERAPEUTICS, INC. | Verwaltungsdirektor | 01.05.2014 | - |
Comptroller/Controller/Auditor | 01.05.2014 | - | |
Finanzdirektor/CFO | 01.05.2014 | - | |
Investor Relations Kontakt | 01.05.2014 | - |
Karriereverlauf von Michael Morneau
Ehemalige bekannte Positionen von Michael Morneau
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 08.09.2010 | 01.01.2014 |
Finanzdirektor/CFO | 10.11.2010 | 09.05.2011 | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.01.2008 | 01.01.2009 |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Comptroller/Controller/Auditor | 01.01.2006 | 01.01.2008 |
Finanzdirektor/CFO | 01.01.2006 | 01.01.2008 | |
MOMENTA PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01.01.2004 | 01.01.2006 |
Gensym Corp.
Gensym Corp. Packaged SoftwareTechnology Services Gensym Corp. engages in the provision of software solutions and services. It offers real-time system development platform for building mission critical process control, production control, and simulation applications. The company was founded by Robert L. Moore & Lowell B. Hawkinson in 1986 and is headquartered in Burlington, MA. | Comptroller/Controller/Auditor | 01.01.2002 | 01.01.2004 |
Ausbildung von Michael Morneau
University of New Hampshire | Undergraduate Degree |
Southern New Hampshire University | Graduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Operativ
Comptroller/Controller/Auditor | 5 |
Director of Finance/CFO | 3 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Technology Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VIKING THERAPEUTICS, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 4 |
---|---|
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
SGX Pharmaceuticals, Inc.
SGX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SGX Pharmaceuticals, Inc. researches and develops drugs and other pharmaceutical products. The company was incorporated in June 20, 1999 and is headquartered in San Diego, CA. | Health Technology |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
Gensym Corp.
Gensym Corp. Packaged SoftwareTechnology Services Gensym Corp. engages in the provision of software solutions and services. It offers real-time system development platform for building mission critical process control, production control, and simulation applications. The company was founded by Robert L. Moore & Lowell B. Hawkinson in 1986 and is headquartered in Burlington, MA. | Technology Services |
- Börse
- Insiders
- Michael Morneau
- Erfahrung